Prepared Foods
  HOME
  Subscribe
  Subscribe to eNewsletter
  Subscription Customer Service
  E-Learning Center
  R&D Application Videos
  New Product Trend Videos
  Special Reports
  Webinars
  Podcasts
  Editorial
  Current Issue
  Issue Archives
  Feature Articles
  Menu Development
  R & D Application
  Daily News
  Digital Issue Archive
  E-dition Exclusives
  Events
  New Products Conference
  Spirit of Innovation Contest (NPC)
  Product Innovation Xchange [PIX] event
  R&D Application Seminar/Chicago
  R&D Applications Seminar East
  Industry Events
  Other Resources
  Food Master Supplier Directory
  Industry Links
  Market Research
  Classified Ads
  IFT Post-Show Review
  Report-based Editorial
  Prepared Foods Info
  Contact Us
  Media Kit
  Reprints
  List Rental
  Related Sites
Search in: EditorialProductsCompanies
Article: Regulations: Claiming Guidance -- June 2009
by Mark Hostetler
June 1, 2009

ARTICLE TOOLS
EmailEmailPrintPrintReprintsReprintsshareShare

The Federal Trade Commission (FTC) has again reiterated the high level of support advertisers must possess prior to making various kinds of objective advertising claims -- including on-label.


Consumers continue to be interested in and demand more than the “good taste” benefits of the food products they consume, and producers are anxious to respond with dietary guidance, “healthier” foods and functional foods. Therefore, the Federal Trade Commission (FTC) has again reiterated the high level of support advertisers must possess prior to making these kinds of objective advertising claims--including on-label (in the matter of Kellogg Company, file no. 0823145).  

Marketing may desire and will certainly expect to rely on their R&D groups for evidence to support marketing’s demands for foods to meet certain claims expectations. Researchers charged with designing foods and vouching for the support of marketing claims made for those products must be cognizant not only of their own professional standards, but of the legal standards which will be used to examine the assumptions, protocols and results of the R&D professionals’ product development and claims support work. R&D personnel efforts in claims development and support can spell the difference between a claim being found to be substantiated and one which can be successfully challenged, resulting in loss of the claim(s), removal of the product from the market and potential legal liability.

* The basic rule of all advertising is that advertisers must have a reasonable basis for making objective claims (claims that are not “puffery”) prior to dissemination of the claims.

* Advertisers must have in their possession at least the level of substantiation expressly or impliedly claimed--including those reasonably inferred--in the advertisement. For example, if the claim is for a particular use or application, there must be evidence of testing of the product for the indicated use or application in support of the claim.

* If there is no specific level of support implied or expressed by the claim (for example, “three out of four doctors” or “clinically shown”), a case-by-case analysis is applied, including type of product and type of claim; benefit of claims, if true, or harm, if false; difficulty in obtaining substantiation; and level of support experts in the field would agree is reasonable.

*  For health and safety claims, including claims of dietary guidance and structure/function, a higher level of support is required: “competent and reliable scientific evidence,” often defined as “tests...or other evidence based upon the expertise of professionals...that has been conducted and evaluated...by persons qualified to do so, using procedures generally accepted in the profession to yield accurate and reliable results.” It stands to reason that a claim of “better for you” ought to be held to a higher level of support than “tastes better than...”

In its recent proceeding, now in the form of a Consent Order for public comment, the FTC argued that a claim that a breakfast food was “clinically proven” to improve children’s “attentiveness” by “nearly 20%” was not supported by clinical research which showed that about half of children eating the food demonstrated any improvement (after three hours) vs. the baseline; that one in seven improved their attentiveness by 18% or more; and only one in seven appeared to improve attentiveness by 20% or more.

As to claims made for meal-eaters vs. meal-skippers, the FTC challenged a claim that attentiveness was improved by 20%. The FTC argued that in the clinical study used to support the claim, eaters had an average of 10.6% better attentiveness (three hours later) than skippers, while “relatively few” experienced better than a 20% improvement.

The FTC’s position was that, taken together, the evidence offered in support of the claims did not rise to the level of “competent and reliable scientific evidence that substantiates the representation.”

While functional foods and dietary guidance advertising are and will continue to be areas of interest for producers and consumers, the support for the claims that R&D professionals will be asked to provide will continue to be scrutinized against a high standard of evidentiary and scientific support. pf


Mark Hostetler
mhostetler@blackwellsanders.com
Mark Hostetler is an attorney at Blackwell Sanders Peper Martin LLP. Experienced in advising consumer product companies and focusing primarily in the food industry, he has guided producers, advertisers and marketers through regulatory proceedings, product recalls, new product introductions, and new advertising and promotional campaigns. He can be reached at mhostetler@blackwellsanders.com.

|PrintEmail

Did you enjoy this article? Click here to subscribe to the magazine.
BNP Media
© 2010 BNP Media. All rights reserved. | Privacy Policy